QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Vol. 17, Issue 5, 2243-2255, May 2006

This Article Full Text Full Text (PDF) Supplemental Material All Versions of this Article: E05-09-0875v1 17/5/2243    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Apaja, P. M. Articles by Petäjä-Repo, U. E. Search for Related Content PubMed PubMed Citation Articles by Apaja, P. M. Articles by Petäjä-Repo, U. E.

Luteinizing Hormone Receptor Ectodomain Splice Variant Misroutes the Full-Length Receptor into a Subcompartment of the Endoplasmic Reticulum

Pirjo M. Apaja ^* , Jussi T. Tuusa ^* , E. Maritta Pietilä ^* , Hannu J. Rajaniemi  , and Ulla E. Petäjä-Repo ^*  

^* Biocenter Oulu, University of Oulu, FI-90014 Oulu, Finland; Department of Anatomy and Cell Biology, University of Oulu, FI-90014 Oulu, Finland

Submitted September 20, 2005; Revised February 6, 2006; Accepted February 13, 2006
Monitoring Editor: Jeffrey Brodsky

The luteinizing hormone receptor (LHR) is a G protein–coupled receptor that is expressed in multiple RNA messenger forms. The common rat ectodomain splice variant is expressed concomitantly with the full-length LHR in tissues and is a truncated transcript corresponding to the partial ectodomain with a unique C-terminal end. Here we demonstrate that the variant alters the behavior of the full-length receptor by misrouting it away from the normal secretory pathway in human embryonic kidney 293 cells. The variant was expressed as two soluble forms of M_r 52,000 and M_r 54,000, but although the protein contains a cleavable signal sequence, no secretion to the medium was observed. Only a very small fraction of the protein was able to gain hormone-binding ability, suggesting that it is retained in the endoplasmic reticulum (ER) by its quality control due to misfolding. This was supported by the finding that the variant was found to interact with calnexin and calreticulin and accumulated together with these ER chaperones in a specialized juxtanuclear subcompartment of the ER. Only proteasomal blockade with lactacystin led to accumulation of the variant in the cytosol. Importantly, coexpression of the variant with the full-length LHR resulted in reduction in the number of receptors that were capable of hormone binding and were expressed at the cell surface and in targeting of immature receptors to the juxtanuclear ER subcompartment. Thus, the variant mediated misrouting of the newly synthesized full-length LHRs may provide a way to regulate the number of cell surface receptors.

Abbreviations used: BSA, bovine serum albumin; CG, chorionic gonadotropin; DDM; n-dodecyl--D-maltoside; Endo H, endo--N-acetylglucosaminidase H; ER, endoplasmic reticulum; ERAD, ER-associated degradation; GPCR, G protein–coupled receptor; HA, haemagglutinin; HEK293, human embryonic kidney 293; LH, luteinizing hormone; µOR, µ opioid receptor; PNGase F, peptide-N-glycosidase F; R, receptor; STI, soybean trypsin inhibitor; UPR, unfolded protein response.

The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org).

These authors contributed equally to this work.

Address correspondence to: Ulla Petäjä-Repo (Ulla.Petaja-Repo{at}oulu.fi) or Hannu Rajaniemi (Hannu.Rajaniemi{at}oulu.fi).

This article has been cited by other articles:

				R. E. Dickinson, A. J. Stewart, M. Myers, R. P. Millar, and W. C. Duncan Differential Expression and Functional Characterization of Luteinizing Hormone Receptor Splice Variants in Human Luteal Cells: Implications for Luteolysis Endocrinology, June 1, 2009; 150(6): 2873 - 2881. [Abstract] [Full Text] [PDF]

				M. T. Duvernay, C. Dong, X. Zhang, F. Zhou, C. D. Nichols, and G. Wu Anterograde Trafficking of G Protein-Coupled Receptors: Function of the C-Terminal F(X)6LL Motif in Export from the Endoplasmic Reticulum Mol. Pharmacol., April 1, 2009; 75(4): 751 - 761. [Abstract] [Full Text] [PDF]

				P. M. H. Markkanen and U. E. Petaja-Repo N-Glycan-mediated Quality Control in the Endoplasmic Reticulum Is Required for the Expression of Correctly Folded {delta}-Opioid Receptors at the Cell Surface J. Biol. Chem., October 24, 2008; 283(43): 29086 - 29098. [Abstract] [Full Text] [PDF]

				A. Kern, D. Hubbard, A. Amano, and G. D. Bryant-Greenwood Cloning, Expression, and Functional Characterization of Relaxin Receptor (Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 7) Splice Variants from Human Fetal Membranes Endocrinology, March 1, 2008; 149(3): 1277 - 1294. [Abstract] [Full Text] [PDF]

				T. T. Leskela, P. M. H. Markkanen, E. M. Pietila, J. T. Tuusa, and U. E. Petaja-Repo Opioid Receptor Pharmacological Chaperones Act by Binding and Stabilizing Newly Synthesized Receptors in the Endoplasmic Reticulum J. Biol. Chem., August 10, 2007; 282(32): 23171 - 23183. [Abstract] [Full Text] [PDF]

				S. K. Shenoy Seven-Transmembrane Receptors and Ubiquitination Circ. Res., April 27, 2007; 100(8): 1142 - 1154. [Abstract] [Full Text] [PDF]

				U. E. Petaja-Repo, M. Hogue, T. T. Leskela, P. M. H. Markkanen, J. T. Tuusa, and M. Bouvier Distinct Subcellular Localization for Constitutive and Agonist-modulated Palmitoylation of the Human {delta} Opioid Receptor J. Biol. Chem., June 9, 2006; 281(23): 15780 - 15789. [Abstract] [Full Text] [PDF]